- 1 Netherlands halts use of AstraZeneca vaccine.
- 2 Canada has not received any AstraZeneca COVID-19 vaccines that were part of the batch under investigation for blood clots, Health Canada confirmed on Sunday.
- 3 Global cases have reached 119,773,122, according to Johns Hopkins University in Baltimore. The worldwide death toll has hit 2,651,754.
- 4 Visit Vietnam Insider’s homepage for more stories.
Netherlands halts use of AstraZeneca vaccine.
Canada has not received any AstraZeneca COVID-19 vaccines that were part of the batch under investigation for blood clots, Health Canada confirmed on Sunday.
Global cases have reached 119,773,122, according to Johns Hopkins University in Baltimore. The worldwide death toll has hit 2,651,754.
Visit Vietnam Insider’s homepage for more stories.
The Netherlands will suspend use of AstraZeneca’s vaccine until at least March 29 as a precaution. The move follows a similar decision by Ireland earlier in the day. The Dutch decision is based on reports from Denmark and Norway of possible serious side effects, the government said.
Ireland temporarily suspended the use of the AstraZeneca Covid-19 vaccine on Sunday following a report from Norway of patients developing blood clots post inoculation, CNN reported.
The Norwegian Medicines Agency on Saturday said there were four new cases of serious blood clotting in adults after taking the vaccine.
Related: Why more and more countries suspend AstraZeneca vaccinations over blood clot fears?
According to a report by Nikkei staff writers, just few hours earlier, AstraZeneca said it had conducted a review of people vaccinated with its vaccine and found no evidence of an increased risk of blood clots. The review covered more than 17 million people vaccinated in the EU and the U.K.
India will also carry out a deeper review of post-vaccination side effects from the AstraZeneca shot next week although no cases of blood clots have been reported so far, an official told AFP Saturday.
New Delhi decided to conduct the review after several countries suspended rollout over blood clot fears even as the World Health Organization said there was no reason to stop using AstraZeneca’s COVID-19 jab.
Italy’s northern region of Piedmont said on Sunday it would stop using a batch of AstraZeneca coronavirus shots after a teacher died following his vaccination on Saturday.
The region, around the northern city of Turin, had initially suspended all AstraZeneca vaccines in order to identify and isolate the batch from which the jab administered to the teacher, from the town of Biella, came.
The decision, following similar moves elsewhere in Europe, was precautionary and the region is awaiting the results of checks which will verify whether there is a connection between the death and the vaccination, the regional government said in an online statement.
Also read: Vietnam continues to use AstraZeneca vaccine
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters in Cambridge, England. AstraZeneca has a portfolio of products for major diseases including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas.
text: ‘Report this ad’,
text: ‘Privacy settings’,